#Japan #Daiichi Sankyo #Tokyo #Bayer #Claritin® EX

Bayer and Daiichi Sankyo Healthcare Sign Licensing Agreement for Claritin® EX

Bayer Pharmaceuticals, headquartered in Osaka, Japan, has officially confirmed its collaboration with Daiichi Sankyo Healthcare, located in Chuo-ku, Tokyo. This partnership centers around the licensing of Bayer's allergy treatment, Claritin® EX, which is classified as a second-class medical product in Japan. The agreement will come into effect on July 1st, 2023, marking the beginning of an important chapter in the distribution of allergy relief solutions in Japan.

Understanding Claritin® EX

Claritin® EX is a second-generation antihistamine medication containing the active ingredient loratadine. Notably, it possesses a unique formulation that minimizes drowsiness, making it an excellent choice for those suffering from allergic rhinitis, such as hay fever. The medication effectively alleviates common symptoms including sneezing, runny nose, and nasal congestion. Its convenient once-daily dosage allows for easy adherence to medication regimens, significantly enhancing patient compliance. Claritin® EX has a robust history as a non-sedating allergy treatment, greatly contributing to improved quality of life (QOL) for many individuals in Japan over the years.

The Background and Goals of the Partnership

Bayer Pharmaceuticals brings a wealth of global expertise in the healthcare sector and specific knowledge regarding enhancing the value of its products, such as Claritin® EX. By partnering with Daiichi Sankyo Healthcare, Bayer aims to leverage their insights into the OTC (over-the-counter) pharmaceuticals market and utilize their extensive distribution network. This collaboration seeks to ensure that individuals in Japan who require allergy relief can access Claritin® EX in a timely and effective manner, thus promoting the advancement of the self-care market in the field of allergies.

Daiichi Sankyo Healthcare has successfully operated within the OTC sector, focusing on various areas including allergy medications, where they primarily provide nasal sprays and eye drops. By integrating an oral medication like Claritin® EX into their product lineup, they aim to fortify their presence in the allergy sector further. Allergic reactions, particularly those triggered by pollen, present daily challenges for many consumers, creating a significant public health issue that has gained attention in recent years. In promoting self-care and self-medication, Daiichi Sankyo Healthcare plans to utilize its established experience in pharmaceutical sales and information delivery to empower consumers to choose and utilize medications appropriately according to their symptoms.

A Commitment to Allergy Relief

Together, Bayer and Daiichi Sankyo Healthcare are committed to delivering Claritin® EX to those suffering from nasal allergies. Their collaboration is geared toward enhancing self-care practices and facilitating better management of allergy symptoms through effective medication options. With a focus on supporting the wellness of individuals dealing with allergies, both companies are dedicated to improving access and treatment outcomes in this vital area of healthcare.

About Daiichi Sankyo Healthcare

As a leading company in the OTC pharmaceuticals space, Daiichi Sankyo Healthcare continues to expand its business domains into functional skincare, oral care, and food sectors. They are committed to enhancing the healthcare landscape and catering to the well-being of consumers. Their corporate slogan, "Fit for You—the Life Partner for a Healthy Life for Everyone," encapsulates their mission to foster an enabling environment for self-care and self-medication practices.

About Bayer Pharmaceuticals

Bayer Pharmaceuticals is dedicated to enhancing treatments through both its medical and consumer health divisions. Their focus lies in addressing high unmet medical needs across various specialty areas including cardiology, nephrology, and oncology, coupled with advances in imaging diagnostics. By delivering innovative medicines, Bayer aims to improve the life expectancy and quality of life for aging demographics in Japan. Furthermore, in their consumer health division, Bayer intensively supports nutritional needs across all stages of life, highlighting their commitment to proactive health management through supplements and dietary initiatives. More information can be found at Bayer Pharmaceuticals as well as on their social media platforms like Facebook and YouTube.

For more details, check the original release here.